The Journal of Clinical Endocrinology & Metabolism · 2014 · 65 citations · 23 references
Transient elevation of liver enzymes and asymptomatic gallbladder pathology were the most prevalent long-term side effects of octreotide therapy. There was no correlation between the dose or the duration of octreotide therapy and development of liver dysfunction and gallbladder pathology.
23